Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | MGAM | O43451 | 2/20 | 0.52 |
| ▸ | SI | P14410 | 2/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | GSK3A | P49840 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL104652 | 1.00 | GAA (0.52) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL9507018 | 0.85 | GAA (0.48) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL28111990 | 0.84 | GAA (0.56) | GAAMGAMSIMGAM2ALDH1A1 | |
| Isopropyl Alcohol SCHEMBL4264567 | 0.84 | GAA (0.61) | GAAMGAMSIMGAM2ALDH1A1 | |
| Isopropyl Alcohol SCHEMBL4612528 | 0.84 | GAA (0.61) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL1330478 | 0.83 | — | — | |
| SCHEMBL15500 | 0.83 | — | — | |
| SCHEMBL1330988 | 0.83 | — | — | |
| SCHEMBL1332259 | 0.83 | — | — | |
| SCHEMBL1331762 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113716911-A | Polymer concrete production process | 张学明 | 2021-11-30 | — | — | CN | claimed |
| CN-107324701-A | Anti-seepage concrete box culvert and preparation method thereof | 安徽砼宇特构科技有限公司 | 2017-11-07 | — | — | CN | claimed |
| CN-107265905-A | Polymer concrete additive, preparation method thereof and concrete | 安徽砼宇特构科技有限公司 | 2017-10-20 | — | — | CN | claimed |
| CN-105131898-B | Preparation method for underwater LED lamp casting glue | 苏州晶雷光电照明科技有限公司 | 2017-10-20 | — | — | CN | claimed |
| US-5166035-A | Multilayer optical recording media with a substrate, recording layer on an under layer with pigment and chelate compound | OLYMPUS OPTICAL CO., LTD. (JP) | 1992-11-24 | — | — | US | claimed |
| US-20260118789-A1 | TONER, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | CANON KK (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12606672-B2 | Curable composition | DAIKIN INDUSTRIES, LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12584028-B2 | Curable organopolysiloxane composition, and optical member formed from cured product of same | DOW TORAY CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-4703406-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703367-A1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703405-A1 | CRYSTALLINE POLYOXYALKYLENE-BASED POLYMER AND CURABLE COMPOSITION COMPRISING SAME | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20260049176-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | KANEKA CORPORATION (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-0512562-A2 | Method of forming coating films | KANSAI PAINT CO., LTD. (JP) | 1992-11-11 | — | — | EP | disclosed |
| EP-0476150-A1 | CURABLE RESIN COMPOSITION | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1992-03-25 | — | — | EP | disclosed |
| EP-0252372-B1 | CURABLE ISOBUTYLENE POLYMER, A CURABLE COMPOSITION CONTAINING IT, AND A CURED PRODUCT THEREOF | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-08-28 | — | — | EP | disclosed |
| US-4976785-A | MODIFIED WITH ALUMINUM CHELATE | NIPPON PAINT CO., LTD. (JP) | 1990-12-11 | — | — | US | disclosed |
| US-4904732-A | Curable isobutylene polymer | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-02-27 | — | — | US | disclosed |
| US-4900772-A | Curable resin composition | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-02-13 | — | — | US | disclosed |
| EP-0287025-A2 | Curable resin composition | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-10-19 | — | — | EP | disclosed |
| EP-0252372-A1 | Curable isobutylene polymer, a curable composition containing it, and a cured product thereof | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049176-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | PSMA1, LIPA, SGMS1 | GAA 145/4885MGAM 291/4885SI 413/4885 |
| US-12606672-B2 | Curable composition | F8, CCNE2, PF4 | GAA 3835/4885MGAM 4058/4885SI 757/4885 |
| US-20260118789-A1 | TONER, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | ACTR8, TECR, SMCHD1 | GAA 121/4885MGAM 2163/4885SI 1663/4885 |
| US-12584028-B2 | Curable organopolysiloxane composition, and optical member formed from cured product of same | MSR1, ILK, F12 | GAA 226/4885MGAM 2154/4885SI 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.